G1 Therapeutics (GTHX)
(Delayed Data from NSDQ)
$3.99 USD
+0.13 (3.37%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $3.98 -0.01 (-0.25%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth B Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/01/2024
Time: BMO |
3/2024 | $-0.19 | 0.00% |
Earnings Summary
For their last quarter, G1 Therapeutics (GTHX) reported earnings of -$0.21 per share, beating the Zacks Consensus Estimate of $-0.27 per share. This reflects a positive earnings surprise of 22.22%. Look out for GTHX's next earnings release on May 01, 2024. For the next earning release, we expect the company to report earnings of -$0.19 per share, reflecting a year-over-year increase of 64.15%.
Earnings History
Price & Consensus
Zacks News for GTHX
Dynavax Technologies (DVAX) Expected to Beat Earnings Estimates: Should You Buy?
GTHX: What are Zacks experts saying now?
Zacks Private Portfolio Services